Funder: National Institutes of Health

Due Dates: May 21, 2025 (Letter of Intent) | June 20, 2025 | February 21, 2025 | February 20, 2026 | June 22, 2026 (Full Applications)

Funding Amounts: No budget limit; actual needs should be justified. Maximum project period: 4 years. Cooperative agreement (U01).

Summary: Supports rigorous analytical validation of biomarker measurement methods for neurological or neuromuscular disorders for clinical trial or practice use.

Key Information: Multi-site applications are encouraged but not required; applications must specify context(s) of use and include milestones.